David R. Bailey
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About David R. Bailey
David R. Bailey is recorded as Board Member and CEO at Orthopediatrics Corp (KIDS). The proxy statement of Orthopediatrics Corp reports total compensation of $3,331,481 for David R. Bailey in fiscal 2025, including a base salary of $550,000. Disclosed compensation is on record for 5 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2021-11-03–present
-
Current
2021-06-03–present
-
Orthopediatrics Corp (KIDS)
SEC 8-K
Current2020-06-03–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Orthopediatrics Corp
Other people whose current roles at this company are on record from its filings.
- Mark C. Throdahl Chairman
- Fred L. Hite CFO, COO
- Fred Hite COO
- Daniel (Dan) Gerritzen General Counsel
- Daniel J. Gerritzen General Counsel
- George S. M. Dyer, MD Board Member
- Jimmy D. McDonald Board Member
- Kelly Fischer Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Orthopediatrics Corp (KIDS) | President and Chief Executive Officer | $550,000 | $3,331,481 |
| 2024 | Orthopediatrics Corp (KIDS) | President and Chief Executive Officer | $550,000 | $3,656,888 |
| 2023 | Orthopediatrics Corp (KIDS) | President and Chief Executive Officer | $500,000 | $2,721,840 |
| 2022 | Orthopediatrics Corp (KIDS) | President and Chief Executive Officer | $415,000 | $1,278,432 |
| 2021 | Orthopediatrics Corp (KIDS) | President and Chief Executive Officer | $371,000 | $906,047 |
Recent activity
No call appearances or filed executive changes recorded yet.